Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,199 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,199 Papers indexed
1,440 Papers AI scored
40,199 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40199 results
C
Pituitary Blastoma: Expanding the Spectrum of Histopathological Findings in a Young Adult With DICER1 Mutation.
PMID 40451220 Published: 2025-06-01 Ingested: 2026-08-02 12:04 AM Neuropathology : official journal of the Japanese Society of Neuropathology
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Time heals. A study of thyroidectomy scars.
PMID 40446385 Published: 2025-05-29 Ingested: 2026-08-02 12:04 AM Brazilian journal of otorhinolaryngology
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Risk assessment of dietary exposure to aflatoxins and their levels in selected staple crops from The Gambia.
PMID 40445027 Published: 2025-05-30 Ingested: 2026-08-02 12:04 AM Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Bisphenol A exposure induces polycystic ovarian syndrome phenotype B and reduces fertility in adolescent female rats.
PMID 40440795 Published: 2025-01-20 Ingested: 2026-08-02 12:03 AM Reproductive biomedicine online
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Role of Interleukin-8 in Hemolytic Uremic Syndrome Severity in Children with Shiga Toxin-Producing Escherichia Coli Infection.
PMID 40440272 Published: 2025-05-29 Ingested: 2026-08-02 12:04 AM Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Spatiotemporal variability, atmospheric chemistry implications and health risk assessment of ambient volatile organic compounds in Central India.
PMID 40439826 Published: 2025-05-29 Ingested: 2026-08-02 12:04 AM Environmental geochemistry and health
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Barriers to Cervical Cancer Screening in India: Insights from National Family Health Survey-5 Data.
PMID 40439399 Published: 2025-05-01 Ingested: 2026-08-02 12:04 AM Asian Pacific journal of cancer prevention : APJCP
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
How perceptions of bone marrow donation costs affect donation behavior: survey evidence from a large donor registry.
PMID 40425906 Published: 2025-05-27 Ingested: 2026-08-02 12:12 AM The European journal of health economics : HEPAC : health economics in prevention and care
AI -
Standard 55.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Previous
Page 2619 of 3350
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic